Back to 
OSAIC HOLDINGS, INC.
OSAIC HOLDINGS, INC.
VRAX3 quarters
Position history for OSAIC HOLDINGS, INC.'s holdings in VIRAX BIOLABS GROUP LTD
No. Osaic exited its VRAX (Virax Biolabs Group) position in Q2 2026. Its Q1 2026 13F listed 20 shares worth $4. Osaic first reported VRAX in Q4 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$7
Total Shares Change
-20
Quarter-by-Quarter History
Other major holders of VRAX: RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Squarepoint Ops LLC, HRT FINANCIAL LP